StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: healthcare · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | BDX Becton Dickinson | $147.12 | -0.87% | $40.5B | 35.6 | 1.9 | +2.4% | 47.0% | 52 |
| 1 | BSX Boston Scientific | $48.31 | -1.63% | $71.8B | 20.1 | 3.5 | +17.4% | 69.1% | 67 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $85.60 |
| -0.81% |
| $149.1B |
| 23.8 |
| 3.3 |
| +6.6% |
| 56.5% |
| 66 |
| 3 | DXCM DexCom | $73.74 | +1.94% | $28.5B | 30.6 | 5.9 | +16.1% | 63.4% | 60 |
| 4 | SYK Stryker | $305.09 | -0.83% | $117.0B | 35.0 | 4.6 | +8.8% | 64.2% | 60 |
| 5 | EW Edwards Lifesciences | $86.47 | +0.59% | $49.8B | 45.4 | 7.9 | +13.8% | 77.9% | 58 |
| 6 | GEHC GE HealthCare | $62.34 | -0.83% | $28.4B | 14.8 | 1.4 | +6.0% | 39.1% | 53 |
| 7 | RMD ResMed | $190.57 | -6.32% | $27.6B | 18.2 | 5.0 | +10.3% | 61.6% | 53 |
| 8 | ZBH Zimmer Biomet | $82.33 | -0.59% | $15.8B | 20.8 | 1.9 | +9.2% | 70.0% | 48 |
| 9 | IDXX IDEXX Laboratories | $563.53 | -0.79% | $44.5B | 40.6 | 10.0 | +13.1% | 62.0% | 47 |